Inactive Instrument

Allergan, Inc. Stock

Stocks

US0184901025

Pharmaceuticals

End-of-day quote NYSE
- ^USD	-

08/06/17	Allergan : Mylan defends chairman to ISS ahead of June 22 investor vote	RE
02/06/17	Allergan : U.S. state, local government lawsuits over opioids face uphill battle	RE

Latest news: Allergan, Inc.

08/06/17	Allergan : Mylan defends chairman to ISS ahead of June 22 investor vote	RE
02/06/17	Allergan : U.S. state, local government lawsuits over opioids face uphill battle	RE
16/05/17	Allergan : Several top fund managers trim Allergan stakes in first quarter	RE
16/05/17	Icahn takes new 19.8 million share stake in Conduent in first quarter	RE
13/05/17	Allergan : High-profile Snap stakeholders revealed in filings	RE
13/05/17	Allergan : High-profile Snap stakeholders revealed in filings	RE
10/05/17	Allergan : posts loss as it writes down Teva holdings	RE
10/05/17	Allergan : posts loss as it writes down Teva holdings	RE
09/05/17	Takeda Pharmaceutical : Sanofi pegs U.S. drug price rises to below healthcare inflation	RE
22/02/17	Allergan : Collapse of Kraft-Unilever tie-up extends run of failed mega-deals	RE
14/02/17	Allergan : to buy fat-fighter Zeltiq Aesthetics for $2.48 billion	RE
14/02/17	Allergan : Stada to hold takeover talks with rival suitors Cinven and Advent	RE
09/02/17	Allergan : says U.S. tax reform unlikely in 2017, sees strong year	RE

Press Releases: Allergan, Inc.

07/06/17	Allergan : to Present New Data on Chronic Migraine at the American Headache Society Meeting in Boston	PU
31/05/17	Allergan : to Present Data from its Anti-Infectives Portfolio at ASM Microbe 2017 in New Orleans	PU
24/05/17	Allergan : Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE™ (Oxymetazoline HCL) Cream, 1%	PU
16/05/17	Allergan : Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays in Our Communications	PU
04/05/17	Allergan : to Present New Data at the 2017 American College of Obstetricians and Gynecologists (ACOG) Clinical and Scientific Meeting in San Diego	PU

More press releases

News in other languages: Allergan, Inc.

12/05/17	Aktien New York: Dow schwächelt erneut - Einzelhandel im Fokus
12/05/17	Aktien New York Ausblick: Erneut moderate Verluste - Einzelhandel im Fokus
11/05/17	WDH/Aktien New York: Dow schwächer - Enttäuschende Unternehmenszahlen
11/05/17	Aktien New York Ausblick: Dow leicht im Minus - Quartalszahlen-Desaster bei Snap
10/05/17	Aktien New York: Leichte Einbußen im frühen Handel

Managers and Directors: Allergan, Inc.

Manager	Title	Age	Since
Scott Reents PSD	President	59	-

Director	Title	Age	Since
Scott Reents BRD	Director/Board Member	59	-

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	ELI LILLY AND COMPANY	+6.63%	+8.10%	+67.50%	+145.20%	1,148B
	JOHNSON & JOHNSON	+1.53%	+6.76%	+47.22%	+89.01%	652B
	ABBVIE INC.	+1.68%	+2.10%	+27.80%	+109.31%	505B
	ROCHE HOLDING AG	+0.73%	+2.47%	+53.85%	+68.96%	384B
	MERCK & CO., INC.	+3.83%	-2.37%	+68.14%	+42.32%	348B
	NOVARTIS AG	+2.38%	+4.27%	+33.81%	+57.95%	294B
	ASTRAZENECA PLC	+2.26%	+3.47%	+5.21%	+28.92%	264B
	AMGEN INC.	+1.97%	+5.11%	+57.74%	+76.14%	244B
	GILEAD SCIENCES, INC.	+4.03%	+7.84%	+40.49%	+116.14%	197B
	Average	+1.55%	+1.39%	+44.64%	+81.55%	448.57B
	Weighted average by Cap.	+1.17%	+1.50%	+49.58%	+95.97%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

As early as today, start finding the best investment opportunities!